During the past decade, Chi-Mei Medical Centre; Hematology & Oncology conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 4 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Chi-Mei Medical Centre; Hematology & Oncology" are "Breast Cancer" (2 trials), "Carcinoma, Hepatocellular" (1 trials), "Esophageal Squamous Cell Carcinoma" (1 trials), "Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer" (1 trials) and "Major Depressive Disorder" (1 trials). Many other conditions were trialed in "Chi-Mei Medical Centre; Hematology & Oncology" in a lesser frequency.

Most popular intervention types in "Chi-Mei Medical Centre; Hematology & Oncology" are "Drug" (8 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (3 trials), "Sorafenib" (2 trials), "Atezolizumab Matching Placebo" (1 trials), "Bevacizumab" (1 trials) and "Erlotinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Chi-Mei Medical Centre; Hematology & Oncology" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Chi-Mei Medical Centre; Hematology & Oncology". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Chi-Mei Medical Centre; Hematology & Oncology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Chi-Mei Medical Centre; Hematology & Oncology, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".